6,030 filings
Page 5 of 100
6-K
80dlit1 r4t
13 Dec 23
Director/pdmr Shareholding
11:02am
6-K
fafia0yw pmj
12 Dec 23
Japan Accepts Arexvy Filing for at Risk Adults
6:06am
6-K
rl5y1eg t1clkga6
11 Dec 23
Jemperli Plus Chemotherapy Eu Authorisation
6:20am
6-K
7q4n08gf4kt90ir8wp
4 Dec 23
GSK Publishes Provisional 2024 Dividend Dates
12:21pm
6-K
vwdq bp1aawdjiai
1 Dec 23
Total Voting Rights
11:31am
6-K
m0r 7xj32xu
30 Nov 23
Block Listing Application
8:08am
6-K
mc0ieig0wmz7ds
29 Nov 23
Holding(s) In Company
12:24pm
6-K
x38t2xt4wsy7gqn9o8m
27 Nov 23
GSK Announces Positive DREAMM-7 Headline Results
9:14am
6-K
g3sjur
21 Nov 23
Director/pdmr Shareholding
11:09am
6-K
f3cgrf
15 Nov 23
Block Listing Interim Review
11:53am
6-K
0tos2ml
13 Nov 23
Director/pdmr Shareholding
12:08pm
6-K
adgg12qft02kg4hxk3
13 Nov 23
GSK Receives Positive CHMP Opinion for Momelotinib
9:04am
6-K
n6ikj9 9q
1 Nov 23
Total Voting Rights
1:01pm
6-K
9hjbd3x8bv8vth6p20
1 Nov 23
3RD Quarter Results
12:51pm
6-K
ghpy0ej 6hs
30 Oct 23
Jemperli Trial Meets Overall Survival Endpoint
7:10am
6-K
ay7 hhw1nxh4i
26 Oct 23
Nmpa Approves Vocabria+rekambys In China
8:17am
6-K
8umys9cs8sxqso
25 Oct 23
Director/pdmr Shareholding
10:47am
6-K
spvwo rdkued0x1kwyt
25 Oct 23
New Data for Arexvy, GSK'S RSV Vaccine
6:38am
6-K
efgmlm
20 Oct 23
Director/pdmr Shareholding
10:54am
6-K
3ocd5jh
18 Oct 23
Director/pdmr Shareholding
12:24pm